Summit Therapeutics (SMMT) Other Gross PP&E Adjustments (2020 - 2025)
Summit Therapeutics (SMMT) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$5.4 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 32.05% year-over-year to -$5.4 million, compared with a TTM value of -$5.4 million through Sep 2025, up 32.05%, and an annual FY2024 reading of -$19.8 million, down 126.21% over the prior year.
- Other Gross PP&E Adjustments was -$5.4 million for Q3 2025 at Summit Therapeutics, up from -$5.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.5 million in Q1 2021 and bottomed at -$19.8 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$5.9 million, with a median of -$5.6 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 2821.8% in 2021, then skyrocketed 36.3% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$3.6 million in 2021, then tumbled by 61.63% to -$5.9 million in 2022, then crashed by 49.39% to -$8.7 million in 2023, then plummeted by 126.21% to -$19.8 million in 2024, then surged by 72.59% to -$5.4 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for SMMT at -$5.4 million in Q3 2025, -$5.6 million in Q2 2025, and -$6.4 million in Q1 2025.